Company intelligence / Profile preview

Intralink-Spine

Lexington, Kentucky, United States

Ownership: Private
Development stage: Other

Overview

Intralink-Spine developed an injectable disc stabilization device (Rejuve/IntraLink) based on plant-derived or naturally derived crosslinking compounds that self-polymerize and bind to collagen within the intervertebral disc to mechanically reinforce and stabilize spinal motion segments, targeting degenerative disc disease and chronic low back pain; early pilot/feasibility studies in Malaysia and Australia reported clinically meaningful improvements in pain (VAS) and disability (ODI) in ≥80% of treated patients up to 2 years, with good tolerability and no intraoperative serious adverse events.[3][5][6]

Therapeutic areas: RheumatologyNeurologyOther
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Intralink-Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intralink-Spine.

Explore the full profile